{"DataElement":{"publicId":"2181368","version":"1","preferredName":"Myeloma Disease Symptom Type","preferredDefinition":"the description of multiple myeloma disease symptoms to classify or group patients by presentation of diagnostic test results.","longName":"MYE_DZ_SM_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2196046","version":"1","preferredName":"Myeloma Disease Symptom","preferredDefinition":"information related to the disease symptoms for myeloma.","longName":"MYE_DZ_SM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206925","version":"1","preferredName":"Myeloma Diseases and Disorders","preferredDefinition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001) -- 2003:A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C3242:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Myeloma","conceptCode":"C3242","definition":"A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia.  Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0F9B-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177304","version":"1","preferredName":"Symptom","preferredDefinition":"An indication that a person has a condition or disease.  Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain.","longName":"Symptom","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-52BE-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE3095C0-7734-2673-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2181366","version":"1","preferredName":"Myeloma Disease Symptom Type","preferredDefinition":"information related to the symptom type for myeloma.","longName":"MYE_DZ_SM_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"133","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Secretory","valueDescription":"Secretory","ValueMeaning":{"publicId":"2566484","version":"1","preferredName":"Secretory","longName":"2566484","preferredDefinition":"A rare, low grade invasive adenocarcinoma of the breast characterized by the presence of cells that secrete milk-like material. Morphologically, it usually appears as a circumscribed lesion, composed of cystic spaces, tubular structures, and solid areas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Secretory Carcinoma","conceptCode":"C4189","definition":"A rare, low grade invasive adenocarcinoma of the breast characterized by the presence of cells that secrete milk-like material. Morphologically, it usually appears as a circumscribed lesion, composed of cystic spaces, tubular structures, and solid areas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0C1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"REEVESD","dateModified":"2013-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D404D5D0-A275-36AA-E034-0003BA12F5E7","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Nonsecretory (no positive immunofixation of serum or urine at baseline)","valueDescription":"Nonsecretory (no positive immunofixation of serum or urine at baseline)","ValueMeaning":{"publicId":"2568461","version":"1","preferredName":"Nonsecretory (no positive immunofixation of serum or urine at baseline)","longName":"2568461","preferredDefinition":"Nonsecretory (no positive immunofixation of serum or urine at baseline)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D87A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D404D5D0-A279-36AA-E034-0003BA12F5E7","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Oligosecretory (at diagnosis, M-protein is present by immunofixation of serum or urine but not quantifiable in either serum or urine)","valueDescription":"Oligosecretory (at diagnosis, M-protein is present by immunofixation of serum or urine but not quantifiable in either serum or urine)","ValueMeaning":{"publicId":"2568462","version":"1","preferredName":"Oligosecretory (at diagnosis, M-protein is present by immunofixation of serum or urine but not quantifiable in either serum or urine)","longName":"2568462","preferredDefinition":"Oligosecretory (at diagnosis, M-protein is present by immunofixation of serum or urine but not quantifiable in either serum or urine)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D87B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D404D5D0-A27D-36AA-E034-0003BA12F5E7","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4083425-6AAD-49FD-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"REEVESD","dateModified":"2010-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811950","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811904","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CRF Text","type":"Preferred Question Text","description":"Type of Disease","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D404B316-C22C-359D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-23","modifiedBy":"CAMPBELB","dateModified":"2005-01-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}